Konicek, D.M.; Plaunt, A.J.; Gharse, S.; Rose, S.J.; Dorfman, A.; Sabnis, A.; Baker, T.; Gauani, H.; Chun, D.; Li, Z.;
et al. Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection. Pharmaceutics 2023, 15, 2250.
https://doi.org/10.3390/pharmaceutics15092250
AMA Style
Konicek DM, Plaunt AJ, Gharse S, Rose SJ, Dorfman A, Sabnis A, Baker T, Gauani H, Chun D, Li Z,
et al. Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection. Pharmaceutics. 2023; 15(9):2250.
https://doi.org/10.3390/pharmaceutics15092250
Chicago/Turabian Style
Konicek, Donna M., Adam J. Plaunt, Sachin Gharse, Sasha J. Rose, Arielle Dorfman, Amruta Sabnis, Thomas Baker, Helena Gauani, Donald Chun, Zhili Li,
and et al. 2023. "Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection" Pharmaceutics 15, no. 9: 2250.
https://doi.org/10.3390/pharmaceutics15092250
APA Style
Konicek, D. M., Plaunt, A. J., Gharse, S., Rose, S. J., Dorfman, A., Sabnis, A., Baker, T., Gauani, H., Chun, D., Li, Z., Perkins, W. R., Cipolla, D., & Malinin, V. S.
(2023). Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection. Pharmaceutics, 15(9), 2250.
https://doi.org/10.3390/pharmaceutics15092250
